HomeMETX • CNSX
add
ME Therapeutics Holdings Inc
Previous close
$9.50
Year range
$0.75 - $11.00
Market cap
281.10M CAD
Avg Volume
148.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 204.81K | 41.18% |
Net income | -199.98K | -39.37% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -198.50K | -36.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.00M | 48.32% |
Total assets | 2.34M | 71.62% |
Total liabilities | 145.29K | — |
Total equity | 2.19M | — |
Shares outstanding | 26.19M | — |
Price to book | 135.71 | — |
Return on assets | -26.26% | — |
Return on capital | -27.45% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -199.98K | -39.37% |
Cash from operations | -207.26K | -108.83% |
Cash from investing | -154.04K | — |
Cash from financing | 1.03M | -2.94% |
Net change in cash | 672.35K | -30.38% |
Free cash flow | -295.50K | — |
About
Founded
2014
Headquarters
Website
